AlzChem Group AG (ACT) — Capital Reinvestment Ratio
AlzChem Group AG (ACT) has a Capital Reinvestment Ratio of 4.54x as of December 2025, meaning it reinvests 5% of its operating cash flow (€21.52 Million) in capital expenditures (€97.79 Million). Check ACT intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
AlzChem Group AG Capital Reinvestment Ratio (2012–2025)
This chart tracks AlzChem Group AG's Capital Reinvestment Ratio across 11 annual periods. For the full cash flow conversion analysis, see AlzChem Group AG cash flow conversion.
Annual Capital Reinvestment Ratio for AlzChem Group AG (2012–2025)
Year-by-year Capital Reinvestment Ratio for AlzChem Group AG from 2012 to 2025. See AlzChem Group AG (ACT) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.71x | €137.01 Million | €97.79 Million | ▲ +74.1% |
| 2024 | 0.41x | €105.15 Million | €43.10 Million | ▲ +44.9% |
| 2023 | 0.28x | €72.67 Million | €20.56 Million | ▼ -57.4% |
| 2021 | 0.66x | €43.02 Million | €28.54 Million | ▲ +12.1% |
| 2020 | 0.59x | €48.71 Million | €28.83 Million | ▼ -37.6% |
| 2019 | 0.95x | €43.63 Million | €41.38 Million | ▼ -18.1% |
| 2018 | 1.16x | €34.66 Million | €40.13 Million | ▲ +42.7% |
| 2017 | 0.81x | €30.66 Million | €24.88 Million | ▼ -100.0% |
| 2014 | 264799.09x | €140.11 | €37.10 Million | ▲ +23027514.6% |
| 2013 | 1.15x | €15.57 Million | €17.91 Million | ▲ +31.7% |
| 2012 | 0.87x | €20.71 Million | €18.08 Million | — |